Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis

• Status: Completed
• Trial end date: 2009-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a multicentre, randomised, double-masked, parallel-group, phase IV comparison of Posiformin 2 % eye ointment (active substance: bibrocathol) in the treatment of blepharitis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ursapharm Arzneimittel GmbH

Criteria

Inclusion Criteria:

• written informed consent

• ambulatory male and female patients 18 years of age or older

• summarised score of signs and symptoms of blepharitis of 15 or more at baseline

Exclusion Criteria:

• different ocular conditions

• different system conditions

• several concomitant medications